{"id":"tp-49667","type":"article-newspaper","title":"Revolution Medicines Shares Rise About 6% After Q3 Results Beat","author":"John Kim","publisher":"TOKENPOST Inc.","url":"https://www.tokenpost.com/news/business/49667","datePublished":"2026-11-06T00:31:32.000Z","dateModified":"2026-11-06T00:31:32.000Z","language":"en","abstract":"The company reaffirmed its 2026 GAAP operating expense range of $2.1 billion to $2.2 billion and posted a $1.90 per-share loss.","section":"Business","references":[]}